Development of a Practical and Reliable Synthesis of Laquinimod
Organic Process Research & Development2007Vol. 11(4), pp. 674–680
Citations Over Time
Abstract
Laquinimod (5-chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinoline carboxamide) is a drug candidate for treatment of Multiple Sclerosis. A short and industrially feasible process for the preparation of laquinimod starting from 2-amino-6-chlorobenzoic acid, in essentially four steps, is dis-cussed. The key step is a novel reaction in which a methyl ester is converted to an amide in very high yield and with excellent purity. The present article elucidates the scale-up process along with safety aspects and the impurity profiles of the intermediates and product. Initial laboratory conditions are described as well as the changes made on transfer to pilot-plant scale.
Related Papers
- → Identification of the metabolites of benzo[f]quinoline and benzo[h]-quinoline formed by rat liver homogenate(1983)11 cited
- Synthesis of Mercaptoalkoxy quinoline Compounds(2002)
- → Synthesis of benzo[g]quinoline derivatives(1970)
- → Carcinogenic Activity of Analogues of <italic>p</italic>-Dimethylaminoazobenzene. IV. Activity of the Quinoline Analogues<xref ref-type="fn" rid="FN1">2</xref>(1961)